KLRK1 and neoplasm: Remarkably, the shed form of the high affinity murine NKG2D ligand, MULT1, induced NK cell activation and tumour rejection via a mechanism that was reported to reverse global NK cell desensitisation imposed by membrane-bound NKG2DLs expressed by tumour-associated cells [152].